Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

Losing weight has officially become more convenient. The popular GLP-1 obesity treatment Wegovy is now available as a once-daily pill. On Monday evening, the Food and Drug Administration approved Novo ...

Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

The agency greenlit an oral version of the obesity drug Wegovy. By Dani Blum The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the FDA for approval on Thursday. Eli Lilly’s LLY drug is called orforglipron.

Orforglipron maintains weight loss after switching from injectable GLP-1 drugs Lilly and Novo Nordisk await U.S. regulatory approvals for weight-loss pills FDA may expedite review of Lilly's ...

Eli Lilly LLY0.88%increase; green up pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

Billy Gardell, 56, opened up about losing 170 pounds since 2021. He also discussed his decision to have bariatric surgery. “It really came down to a shift in everything I think about food,” he said.

Kelly Osbourne has finally spoken out about her weight loss. The singer’s mother, Sharon Osbourne, recently appeared on “Piers Morgan Uncensored.” During the interview, the host played a social media ...

Retatrutide works by mimicking three hunger-regulating hormones. A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...